Navigation Links
Raptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation in Non-Alcoholic Steatohepatitis (NASH)
Date:10/20/2008

steamine for the treatment of nephropathic cystinosis, through its December 2007 acquisition of Encode Pharmaceuticals. In March 2008, Raptor acquired an exclusive worldwide license to intellectual property from UCSD for the use of cysteamine and DR Cysteamine for the treatment of NASH.

About Raptor Pharmaceuticals Corp.

Raptor Pharmaceuticals Corp. ("Raptor") is a publicly traded biotechnology company dedicated to speeding the delivery of new treatment options to patients by enhancing existing therapeutics through the application of highly specialized drug targeting platforms and formulation expertise. Raptor focuses on underserved patient populations where it can have the greatest impact. Raptor is involved in clinical development of its proprietary Delayed-Release Cysteamine ("DR Cysteamine") product candidate in nephropathic cystinosis, non-alcoholic steatohepatitis ("NASH"), Huntington's Disease and Batten Disease, and its Convivia(TM) product candidate in aldehyde dehydrogenase ("ALDH2") deficiency. In its preclinical programs Raptor bioengineers novel drug candidates and drug-targeting platforms derived from the human receptor-associated protein ("RAP") and related proteins to target cancer, neurodegenerative disorders and infectious diseases. Raptor's preclinical programs include HepTide(TM), WntTide(TM) and NeuroTrans(TM).

For additional information, please visit http://www.raptorpharma.com.

FORWARD LOOKING STATEMENTS

This document contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements relate to future events or our future results of operation or future financial performance, including, but not limited to the following statements: Raptor's ability to develop DR Cysteamine for the treatment of NASH, cystinosis and other indications; Raptor's ability to formulate and manufacture DR Cysteamine
'/>"/>

SOURCE Raptor Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
2. Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)
3. Raptor Pharmaceuticals Provides Update of Product Programs
4. Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy
5. Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial
6. Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement
7. Access Pharmaceuticals Presents New Data on the Companys Angiolix(R) Therapeutic Monoclonal Antibody
8. Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society
9. Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings
10. Critical Pharmaceuticals Enter Sustained Release hGH Arena
11. Anadys Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... DENVER, Dec. 14 Corgenix Medical ... developer and marketer of diagnostic test kits, ... Massachusetts-based life sciences company, announced today a ... Galectin-3 diagnostic products in enzyme-linked immunosorbent assay ... BG Medicine is seeking regulatory clearance in ...
(Date:12/14/2009)... 14 Southridge LLC ("Southridge"), an ... companies, is pleased to announce that its affiliated fund ... to $15 million in equity financing to Imaging Diagnostic ... years of financing the growth of Imaging Diagnostic Systems, ... produce new developments in the field of early breast ...
(Date:12/14/2009)... /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC. (OTC ... received a complete response letter from the U.S. ... New Drug Application ("NDA") for Onrigin(TM) (laromustine) injection ... that the FDA cannot approve the Company,s NDA ... address remaining issues. ,, Alan Kessman, Chief Executive ...
Breaking Medicine Technology:Corgenix and BG Medicine Announce Supply Agreement for BGM Galectin-3(TM) 2Southridge LLC Provides Funding Through Private Equity Agreement with Imaging Diagnostic Systems, Inc. 2Vion Pharmaceuticals Receives Complete Response Letter for Onrigin(TM) From The U.S. Food And Drug Administration 2Vion Pharmaceuticals Receives Complete Response Letter for Onrigin(TM) From The U.S. Food And Drug Administration 3Oncolytics Biotech 28R 29 Inc Accelerates Warrant Expiry Date 14341 1Oncolytics Biotech 28R 29 Inc Accelerates Warrant Expiry Date 14341 2University Hospitals Case Medical Center earns prestigious national award for excellence 58801 1University Hospitals Case Medical Center earns prestigious national award for excellence 58801 2Fresh Blood Boosts Survival in Trauma Patients 58799 1Fresh Blood Boosts Survival in Trauma Patients 58799 2
... Jan. 8 Corthera Inc. today announced,the initiation ... trial of,Relaxin, a naturally occurring peptide hormone that ... acute care illnesses., The trial will investigate ... acute heart failure. Approximately 330 patients will be,recruited ...
... 7 Baxter International,Inc. (NYSE: BAX ) ... develop recombinant Factor IX proteins to treat hemophilia ... IX therapy for,treatment of acute bleeding episodes and ... therapy for prophylaxis of bleeding in,hemophilia B patients. ...
Other Medicine Technology:Corthera Initiates Phase II Clinical Trial of Relaxin in Acute Heart Failure 2Baxter Announces Recombinant Factor IX Development Program For Hemophilia B 2Baxter Announces Recombinant Factor IX Development Program For Hemophilia B 3
(Date:12/14/2009)... be linked to scans performed in 2007 , , MONDAY, ... exposing patients to far more radiation than previously thought and ... a year, two new studies claim. , Based on the ... Archives of Internal Medicine , the study authors, joined by ... on clinicians to limit radiation exposure to patients. , "CT ...
(Date:12/14/2009)... poorly treated and highly stigmatized, according to psychiatrists ... M.D., Ph.D. So these Washington University physicians have ... In "Demystifying Psychiatry," Zorumski and Rubin, who have ... patients and helping patient families, say some of ... result from a lack of understanding psychiatry and ...
(Date:12/14/2009)... Association (NBA) and the United Nations Foundation’s Nothing But Nets tipped ... presented by HP--to send anti-malaria bed nets to refugees in 11 ... of Giving and runs through January 31, 2010. ... ... Today, the National Basketball Association (NBA) and the United Nations Foundation’s ...
(Date:12/14/2009)... Dec. 14 Josie Raper, a 29 year-old mother ... six months with the help of the Dr. Siegal,s COOKIE ... the Joy Fit Club segment on NBC,s Today Show. The ... Bauer, airs twice a month and salutes those who have ... 2007 and has kept it off for two years. ,, ...
(Date:12/14/2009)... Athens, Ga. A new study published by researchers ... Center in Tampa, Fla., has found that cancer patients ... patients with cancer alone, even after controlling for factors ... But the study, published in the early online edition ... also argues that a diagnosis of dementia shouldn,t discourage ...
Breaking Medicine News(10 mins):Health News:Studies Quantify Cancer Risks From CT Scans 2Health News:Studies Quantify Cancer Risks From CT Scans 3Health News:Studies Quantify Cancer Risks From CT Scans 4Health News:Book demystifies psychiatry for the general public 2Health News:Book demystifies psychiatry for the general public 3Health News:NBA Cares and United Nations Foundation Partner to Launch Send A Net. Save A Life. See A Game. Presented By HP 2Health News:NBA Cares and United Nations Foundation Partner to Launch Send A Net. Save A Life. See A Game. Presented By HP 3Health News:NBA Cares and United Nations Foundation Partner to Launch Send A Net. Save A Life. See A Game. Presented By HP 4Health News:Size 24 to 6 in Just 6 Months: NBC's Today Show Celebrates Dr. Siegal's Cookie Diet Success Story on Joy Fit Club 2Health News:Size 24 to 6 in Just 6 Months: NBC's Today Show Celebrates Dr. Siegal's Cookie Diet Success Story on Joy Fit Club 3Health News:Size 24 to 6 in Just 6 Months: NBC's Today Show Celebrates Dr. Siegal's Cookie Diet Success Story on Joy Fit Club 4Health News:Study finds significantly worse outcomes in cancer patients with cognitive impairment 2Health News:Study finds significantly worse outcomes in cancer patients with cognitive impairment 3
... about $247 billion a year, experts say , , FRIDAY, ... problems in young Americans cost the nation about $247 ... federal government to make preventing these disorders and promoting ... Problems such as depression, anxiety, conduct disorders and substance ...
... Smart Balance, Inc. (Nasdaq: SMBL ) announced ... Balance, Inc., will make a presentation at the Roth Capital ... at 2 p.m. EST on Tuesday, February 17, 2009.Smart Balance,s ... conference attendees will be able to ask questions, but listeners ...
... Twenty-seven leading organizations from the clinical research community ... The American National Standards Institute ... conformity assessment system, is working to facilitate the ... clinical research activities. The Institute seeks the active ...
... DYNT ) today announced results for its fiscal ... results showed significant improvement over the three and six months ... December 31, 2008, improved to $89,917, compared to a pre-tax ... fiscal year. Net income for the quarter ended December 31, ...
... ), today announced that its Chief Financial Officer, Buck Phillips, will present ... Ritz-Carlton Laguna Niguel on Wednesday, February 18, 2009., Forum: ... Date: Wednesday, February 18, 2009, Time: ... Ritz-Carlton Laguna Niguel, ...
... New techniques used to examine hormones in feces and ... results about hormones and evolution. The new techniques allow ... range of mammals. , San Francisco State Biology Professor ... that examine social stress and how they correlate to ...
Other Medicine News:Health News:Report Urges Broader Effort to Stem Emotional Disorders in Youth 2Health News:ANSI Seeks Funding to Ensure that Electronic Health Records Will Support Clinical Research Activities 2Health News:ANSI Seeks Funding to Ensure that Electronic Health Records Will Support Clinical Research Activities 3Health News:ANSI Seeks Funding to Ensure that Electronic Health Records Will Support Clinical Research Activities 4Health News:Dynatronics Reports Profitable Second Quarter - Signaling Significant Improvement Over Prior Year Results 2Health News:Dynatronics Reports Profitable Second Quarter - Signaling Significant Improvement Over Prior Year Results 3Health News:Dynatronics Reports Profitable Second Quarter - Signaling Significant Improvement Over Prior Year Results 4Health News:Micromet To Present at the ROTH 21st Annual Orange County Growth Stock Conference 2Health News:Micromet To Present at the ROTH 21st Annual Orange County Growth Stock Conference 3Health News:Micromet To Present at the ROTH 21st Annual Orange County Growth Stock Conference 4Health News:Findings raise new questions about evolution of hormones in mammals 2
The AXIOM Artis TC is ideal for applications above and beyond standard cardioangiography, and features:, Single plane C-Arm, ceiling-mounted, Full-size CCD camera, ...
... Hybrid Imaging in Cardiology ... unmatched imaging solutions in cardiology. ... quality coronary CT angiography imaging ... visibility. Symbia TruePoint SPECTCT ...
... enables you to scan every beating heart at ... dose possible. A scanner using two X-ray ... It provides one-stop diagnosis in acute care; even ... rate. Combined with the Cardiac Engine, a unique ...
... paperless environment, providers can code the charge while ... their PDA while away from office, both directly ... to use an Encounter Form/Superbill, data entry can ... Insurance and patient payments are posted by reflecting ...
Medicine Products: